Clin2
NCT06323824Likely a fitRecruiting

Methadone vs. buprenorphine for opioid use disorder treatment

Opioid Use Disorder

Treatments studied

Part of Mental health clinical trials.

This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
600 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have been diagnosed with opioid use disorder (addiction to opioids)
  • You are starting a new treatment for opioid use disorder
  • You are not taking more than 3 days of medication for opioid addiction in the past week
  • You are willing to be randomly assigned to either methadone or buprenorphine and follow the study plan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07469501Not yet recruiting· Phase 4
Comparing low-dose vs. direct-inject buprenorphine for fentanyl users

This study compares two ways to start buprenorphine (a medicine for opioid use disorder) for people who use fentanyl daily. One group gets a low starting dose, the other gets a direct injection. The goal is to see which approach helps people stay in treatment longer.

San Francisco, California
NCT06494904Recruiting· Phase 3
Standard vs. High Dose Buprenorphine in the ER

This study compares a higher dose of buprenorphine (a medicine that helps stop opioid cravings and withdrawal) to the usual dose, given in the emergency department. It aims to see if the higher dose works better to start treatment for opioid use disorder.

Oakland, California
NCT04375033Recruiting· Phase 4
Oral versus injection buprenorphine for opioid use disorder

This trial compares taking buprenorphine by mouth versus as an injection for opioid use disorder. It aims to see which option helps people stay on treatment and reduces opioid use over about a year.

Tuscaloosa, Alabama
NCT06726200Recruiting· Early Phase 1
Comparing buprenorphine formulations for fentanyl addiction

This study tests two different forms of buprenorphine (a medication for opioid addiction) to see which works better for people who use fentanyl or other strong synthetic opioids. If you are seeking treatment for opioid use, this trial may help you find the most effective option.

New York, New York
NCT05450718Recruiting· Phase 4
Low-dose buprenorphine start for opioid use disorder

This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.

The Bronx, New York
NCT06316830Recruiting· Phase 2/Phase 3
Finding the best buprenorphine dose for opioid use disorder

This trial tests different doses of buprenorphine to find the safest and most effective one for treating opioid use disorder and preventing overdose. It is for people who have used fentanyl and are starting or continuing buprenorphine treatment.

Providence, Rhode Island

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.